Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

IgA production requires B cell interaction with subepithelial dendritic cells in Peyer's patches.

Reboldi A, Arnon TI, Rodda LB, Atakilit A, Sheppard D, Cyster JG.

Science. 2016 May 13;352(6287):aaf4822. doi: 10.1126/science.aaf4822.

2.

Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.

Arnon TI, Markel G, Bar-Ilan A, Hanna J, Fima E, Benchetrit F, Galili R, Cerwenka A, Benharroch D, Sion-Vardy N, Porgador A, Mandelboim O.

PLoS One. 2015 May 4;10(5):e0128052. doi: 10.1371/journal.pone.0128052. eCollection 2015. No abstract available.

3.

Retraction. Novel APC-like properties of human NK cells directly regulate T cell activation.

Hanna J, Gonen-Gross T, Fitchett J, Rowe T, Daniels M, Arnon TI, Gazit R, Joseph A, Schjetne KW, Steinle A, Porgador A, Mevorach D, Goldman-Wohl D, Yagel S, LaBarre MJ, Buckner JH, Mandelboim O.

J Clin Invest. 2015 Apr;125(4):1763. doi: 10.1172/JCI81527. Epub 2015 Apr 1. No abstract available.

4.

Blood, sphingosine-1-phosphate and lymphocyte migration dynamics in the spleen.

Arnon TI, Cyster JG.

Curr Top Microbiol Immunol. 2014;378:107-28. doi: 10.1007/978-3-319-05879-5_5. Review.

PMID:
24728595
5.

Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress.

Arnon TI, Horton RM, Grigorova IL, Cyster JG.

Nature. 2013 Jan 31;493(7434):684-8. doi: 10.1038/nature11738. Epub 2012 Dec 23.

6.

GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood.

Arnon TI, Xu Y, Lo C, Pham T, An J, Coughlin S, Dorn GW, Cyster JG.

Science. 2011 Sep 30;333(6051):1898-903. doi: 10.1126/science.1208248.

7.

Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone.

Muppidi JR, Arnon TI, Bronevetsky Y, Veerapen N, Tanaka M, Besra GS, Cyster JG.

J Exp Med. 2011 Sep 26;208(10):1941-8. doi: 10.1084/jem.20111083. Epub 2011 Aug 29.

8.

The crystal structure of CHIR-AB1: a primordial avian classical Fc receptor.

Arnon TI, Kaiser JT, West AP Jr, Olson R, Diskin R, Viertlboeck BC, Göbel TW, Bjorkman PJ.

J Mol Biol. 2008 Sep 12;381(4):1012-24. doi: 10.1016/j.jmb.2008.06.082. Epub 2008 Jul 3.

9.

Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.

Arnon TI, Markel G, Bar-Ilan A, Hanna J, Fima E, Benchetrit F, Galili R, Cerwenka A, Benharroch D, Sion-Vardy N, Porgador A, Mandelboim O.

PLoS One. 2008 May 14;3(5):e2150. doi: 10.1371/journal.pone.0002150. Erratum in: PLoS ONE. 2008;3(5). doi: 10.1371/annotation/eaf9794a-9325-4977-952d-51285c3f6c6a. PLoS One. 2015;10(5):e0128052.

10.

Tumor and viral recognition by natural killer cells receptors.

Arnon TI, Markel G, Mandelboim O.

Semin Cancer Biol. 2006 Oct;16(5):348-58. Epub 2006 Jul 7. Review.

PMID:
16893656
11.

Decidual NK cells regulate key developmental processes at the human fetal-maternal interface.

Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O.

Nat Med. 2006 Sep;12(9):1065-74. Epub 2006 Aug 6.

PMID:
16892062
12.

Reduced KIR2DL1 recognition of MHC class I molecules presenting phosphorylated peptides.

Betser-Cohen G, Katz G, Gonen-Gross T, Stern N, Arnon TI, Achdout H, Gazit R, Mandelboim O.

J Immunol. 2006 Jun 1;176(11):6762-9.

13.

Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1.

Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H, Hanna J, Qimron U, Landau G, Greenbaum E, Zakay-Rones Z, Porgador A, Mandelboim O.

Nat Immunol. 2006 May;7(5):517-23. Epub 2006 Mar 26.

PMID:
16565719
14.

The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules.

Gonen-Gross T, Achdout H, Arnon TI, Gazit R, Stern N, Horejsí V, Goldman-Wohl D, Yagel S, Mandelboim O.

J Immunol. 2005 Oct 15;175(8):4866-74.

15.

Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency.

Hanna J, Mussaffi H, Steuer G, Hanna S, Deeb M, Blau H, Arnon TI, Weizman N, Mandelboim O.

Blood. 2005 Nov 15;106(10):3465-73. Epub 2005 Jul 21. Erratum in: Blood. 2015 Apr 16;125(16):2583.

PMID:
16037391
16.

The involvement of NK cells in ankylosing spondylitis.

Azuz-Lieberman N, Markel G, Mizrahi S, Gazit R, Hanna J, Achdout H, Gruda R, Katz G, Arnon TI, Battat S, Zamir E, Adawi M, Mader R, Mandelboim O.

Int Immunol. 2005 Jul;17(7):837-45. Epub 2005 Jun 3.

PMID:
15937057
17.

Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.

Stern N, Markel G, Arnon TI, Gruda R, Wong H, Gray-Owen SD, Mandelboim O.

J Immunol. 2005 Jun 1;174(11):6692-701.

18.

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J, Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, Mandelboim O.

Nat Immunol. 2005 May;6(5):515-23. Epub 2005 Apr 10.

PMID:
15821739
19.

Novel APC-like properties of human NK cells directly regulate T cell activation.

Hanna J, Gonen-Gross T, Fitchett J, Rowe T, Daniels M, Arnon TI, Gazit R, Joseph A, Schjetne KW, Steinle A, Porgador A, Mevorach D, Goldman-Wohl D, Yagel S, LaBarre MJ, Buckner JH, Mandelboim O.

J Clin Invest. 2004 Dec;114(11):1612-23. Retraction in: J Clin Invest. 2015 Apr;125(4):1763.

20.

MHC class I-independent recognition of NK-activating receptor KIR2DS4.

Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, Markel G, Gruda R, Achdout H, Drize O, Merims S, Mandelboim O.

J Immunol. 2004 Aug 1;173(3):1819-25.

21.

Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients.

Markel G, Achdout H, Katz G, Ling KL, Salio M, Gruda R, Gazit R, Mizrahi S, Hanna J, Gonen-Gross T, Arnon TI, Lieberman N, Stren N, Nachmias B, Blumberg RS, Steuer G, Blau H, Cerundolo V, Mussaffi H, Mandelboim O.

Eur J Immunol. 2004 Aug;34(8):2138-48.

22.

Recognition of Mycoplasma hyorhinis by CD99-Fc molecule.

Gazit R, Rechnitzer H, Achdout H, Katzenell A, Katz G, Markel G, Arnon TI, Gonen-Gross T, Mizrahi S, Gruda R, Rottem S, Mandelboim O.

Eur J Immunol. 2004 Jul;34(7):2032-40.

23.

The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients.

Markel G, Mussaffi H, Ling KL, Salio M, Gadola S, Steuer G, Blau H, Achdout H, de Miguel M, Gonen-Gross T, Hanna J, Arnon TI, Qimron U, Volovitz I, Eisenbach L, Blumberg RS, Porgador A, Cerundolo V, Mandelboim O.

Blood. 2004 Mar 1;103(5):1770-8. Epub 2003 Nov 6. Erratum in: Blood. 2015 Mar 19;125(12):2006.

PMID:
14604968
24.

The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46.

Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, Katz G, Bar-Ilan A, Bloushtain N, Lev M, Joseph A, Kedar E, Porgador A, Mandelboim O.

Blood. 2004 Jan 15;103(2):664-72. Epub 2003 Sep 22.

PMID:
14504081
25.

Enhanced recognition of human NK receptors after influenza virus infection.

Achdout H, Arnon TI, Markel G, Gonen-Gross T, Katz G, Lieberman N, Gazit R, Joseph A, Kedar E, Mandelboim O.

J Immunol. 2003 Jul 15;171(2):915-23.

26.

CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.

Markel G, Lieberman N, Katz G, Arnon TI, Lotem M, Drize O, Blumberg RS, Bar-Haim E, Mader R, Eisenbach L, Mandelboim O.

J Immunol. 2002 Mar 15;168(6):2803-10.

27.

Recognition of viral hemagglutinins by NKp44 but not by NKp30.

Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O.

Eur J Immunol. 2001 Sep;31(9):2680-9.

28.

Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4.

Katz G, Markel G, Mizrahi S, Arnon TI, Mandelboim O.

J Immunol. 2001 Jun 15;166(12):7260-7.

29.

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.

Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A.

Nature. 2001 Feb 22;409(6823):1055-60.

PMID:
11234016

Supplemental Content

Loading ...
Support Center